Simplex Trading’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-132,600
| Closed | -$13.3K | – | 8996 |
|
|
2025
Q4 | $13.3K | Sell |
132,600
-527,700
| -80% | -$335K | ﹤0.01% | 6802 |
|
|
2025
Q3 | $399K | Buy |
660,300
+410,000
| +164% | +$193K | ﹤0.01% | 4113 |
|
|
2025
Q2 | $77K | Sell |
250,300
-2,700
| -1% | -$1.04K | ﹤0.01% | 5482 |
|
|
2025
Q1 | $123K | Buy |
253,000
+120,600
| +91% | +$71K | ﹤0.01% | 4847 |
|
|
2024
Q4 | $113K | Buy |
132,400
+57,300
| +76% | +$359K | ﹤0.01% | 5067 |
|
|
2024
Q3 | $638K | Sell |
75,100
-50,200
| -40% | -$296K | ﹤0.01% | 3331 |
|
|
2024
Q2 | $585K | Sell |
125,300
-245,500
| -66% | -$1.16M | ﹤0.01% | 3497 |
|
|
2024
Q1 | $2.52M | Buy |
370,800
+350,600
| +1,736% | +$1.57M | ﹤0.01% | 2174 |
|
|
2023
Q4 | $67K | Sell |
20,200
-67,200
| -77% | -$167K | ﹤0.01% | 5787 |
|
|
2023
Q3 | $217K | Buy |
87,400
+57,500
| +192% | +$94.8K | ﹤0.01% | 4247 |
|
|
2023
Q2 | $38K | Buy |
29,900
+8,400
| +39% | +$11.1K | ﹤0.01% | 6092 |
|
|
2023
Q1 | $17K | Sell |
21,500
-51,200
| -70% | -$50.4K | ﹤0.01% | 7042 |
|
|
2022
Q4 | $55K | Sell |
72,700
-95,700
| -57% | -$75.7K | ﹤0.01% | 5746 |
|
|
2022
Q3 | $156K | Buy |
+168,400
| New | +$202K | ﹤0.01% | 4942 |
|
|
2022
Q2 | – | Sell |
-9,500
| Closed | -$20K | – | 9875 |
|
|
2022
Q1 | $20K | Sell |
9,500
-3,000
| -24% | -$8.04K | ﹤0.01% | 8236 |
|
|
2021
Q4 | $111K | Buy |
+12,500
| New | +$164K | ﹤0.01% | 6078 |
|
|
2021
Q2 | – | Sell |
-35
| Closed | -$65K | – | 9974 |
|
|
2021
Q1 | $65K | Buy |
+35
| New | +$755 | ﹤0.01% | 6286 |
|
Simplex Trading's APLT Position: Q4 2024 in Review
Simplex Trading sold out of Applied Therapeutics (APLT) in Q4 2024, closing a stake of 6,071 shares — an estimated $38.1K sold.
Simplex Trading first reported a position in APLT in Q4 2020 and held it in 11 quarters. The position peaked at $799K in Q4 2020. 118 funds tracked by Wall St. Rank hold APLT as of Q4 2024.
- Simplex Trading reported no remaining Applied Therapeutics position as of Q4 2024 after selling out during the quarter.
- Simplex Trading sold 6,071 Applied Therapeutics shares in Q4 2024, an estimated $38.1K.
- Simplex Trading first reported a position in Applied Therapeutics in Q4 2020 and held it in 11 quarters.
- Simplex Trading's Applied Therapeutics position peaked at $799K in Q4 2020.
- 118 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2024.
Based on Simplex Trading's 13F filing for Q4 2024, filed 11 Feb 2025.